Skip to main content
. 2021 May 4;16(5):e0250993. doi: 10.1371/journal.pone.0250993

Fig 1. Selection of study cohorts.

Fig 1

All patients received metformin monotherapy in a pre-index period of one year and added sitagliptin either as a fixed-dose combination or loose dose combination in a post-index period of three years.